Integrated Chronic In Vivo and In Vitro Screens Uncover NFIL3 as a Driver of T-cell Dysfunction.

Saved in:
Bibliographic Details
Title: Integrated Chronic In Vivo and In Vitro Screens Uncover NFIL3 as a Driver of T-cell Dysfunction.
Authors: Jain N; Columbia Initiative in Cell Engineering and Therapy (CICET), Vagelos College of Physicians and Surgeons, Columbia University Irving Medical Center, Columbia University, New York, New York., Shi Y; Columbia Initiative in Cell Engineering and Therapy (CICET), Vagelos College of Physicians and Surgeons, Columbia University Irving Medical Center, Columbia University, New York, New York., May C; Cluster of Excellence iFIT (EXC2180) 'Image-Guided and Functionally Instructed Tumor Therapies', University of Tübingen, Tübingen, Germany.; Department of Pediatric Hematology and Oncology, University Children's Hospital Tübingen, University of Tübingen, Tübingen, Germany., Mitra S; Computational & Systems Biology Program, Sloan Kettering Institute, New York, New York., Bucher P; Cluster of Excellence iFIT (EXC2180) 'Image-Guided and Functionally Instructed Tumor Therapies', University of Tübingen, Tübingen, Germany.; Department of Pediatric Hematology and Oncology, University Children's Hospital Tübingen, University of Tübingen, Tübingen, Germany., Dobrin A; Department of Immunology, Sunnybrook Research Institute, University of Toronto, Toronto, Canada., Zhao Z; Columbia Initiative in Cell Engineering and Therapy (CICET), Vagelos College of Physicians and Surgeons, Columbia University Irving Medical Center, Columbia University, New York, New York., Hanina S; Columbia Initiative in Cell Engineering and Therapy (CICET), Vagelos College of Physicians and Surgeons, Columbia University Irving Medical Center, Columbia University, New York, New York., Rajasekhar VK; Orthopedic Service, Department of Surgery, Memorial Hospital, New York, New York., Yao Y; Columbia Initiative in Cell Engineering and Therapy (CICET), Vagelos College of Physicians and Surgeons, Columbia University Irving Medical Center, Columbia University, New York, New York., Mansilla-Soto J; Department of Immunology, H. Lee Moffitt Cancer Center, Tampa, Florida.; Department of Bioengineering, H. Lee Moffitt Cancer Center, Tampa, Florida.; Department of BMT and Cellular Immunotherapy, H. Lee Moffitt Cancer Center, Tampa, Florida., Leibold J; Cluster of Excellence iFIT (EXC2180) 'Image-Guided and Functionally Instructed Tumor Therapies', University of Tübingen, Tübingen, Germany.; Department of Medical Oncology and Pneumology (Internal Medicine VIII), University Hospital Tübingen, Tübingen, Germany., Leslie CS; Computational & Systems Biology Program, Sloan Kettering Institute, New York, New York., Sánchez-Rivera FJ; Department of Biology, Massachusetts Institute of Technology, Cambridge, Massachusetts.; David H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, Massachusetts., Feucht J; Cluster of Excellence iFIT (EXC2180) 'Image-Guided and Functionally Instructed Tumor Therapies', University of Tübingen, Tübingen, Germany.; Department of Pediatric Hematology and Oncology, University Children's Hospital Tübingen, University of Tübingen, Tübingen, Germany., Sadelain M; Columbia Initiative in Cell Engineering and Therapy (CICET), Vagelos College of Physicians and Surgeons, Columbia University Irving Medical Center, Columbia University, New York, New York.
Source: Cancer discovery [Cancer Discov] 2026 Jul 01; Vol. 16 (7), pp. 1456-1471.
Publication Type: Journal Article
Journal Info: Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 101561693 Publication Model: Print Cited Medium: Internet ISSN: 2159-8290 (Electronic) Linking ISSN: 21598274 NLM ISO Abbreviation: Cancer Discov Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2159-8290
DOI:10.1158/2159-8290.CD-25-1524